vs
Side-by-side financial comparison of ARCBEST CORP (ARCB) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $998.8M, roughly 1.3× ARCBEST CORP). HAEMONETICS CORP runs the higher net margin — 7.3% vs -0.1%, a 7.4% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs 3.3%). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs -3.7%).
ArcBest Corporation is a leading U.S.-based logistics and transportation solutions provider. It offers end-to-end supply chain services including less-than-truckload freight shipping, full truckload services, warehousing, expedited delivery, and customized logistics consulting, serving enterprise, small business, and government clients across North America and select global markets.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
ARCB vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $998.8M | $1.3B |
| Net Profit | $-1.0M | $97.3M |
| Gross Margin | — | 14.9% |
| Operating Margin | 0.3% | 83.4% |
| Net Margin | -0.1% | 7.3% |
| Revenue YoY | 3.3% | 4.8% |
| Net Profit YoY | -133.1% | -42.0% |
| EPS (diluted) | $-0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $998.8M | $1.3B | ||
| Q4 25 | $972.7M | $339.0M | ||
| Q3 25 | $1.0B | $327.3M | ||
| Q2 25 | $1.0B | $321.4M | ||
| Q1 25 | $967.1M | $330.6M | ||
| Q4 24 | $1.0B | $348.5M | ||
| Q3 24 | $1.1B | $345.5M | ||
| Q2 24 | $1.1B | $336.2M |
| Q1 26 | $-1.0M | $97.3M | ||
| Q4 25 | $-8.1M | $44.7M | ||
| Q3 25 | $39.3M | $38.7M | ||
| Q2 25 | $25.8M | $34.0M | ||
| Q1 25 | $3.1M | $58.0M | ||
| Q4 24 | $29.0M | $37.5M | ||
| Q3 24 | $100.3M | $33.8M | ||
| Q2 24 | $46.9M | $38.4M |
| Q1 26 | — | 14.9% | ||
| Q4 25 | — | 59.7% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 59.8% | ||
| Q1 25 | — | 58.4% | ||
| Q4 24 | — | 55.5% | ||
| Q3 24 | — | 54.2% | ||
| Q2 24 | — | 52.0% |
| Q1 26 | 0.3% | 83.4% | ||
| Q4 25 | -0.8% | 19.9% | ||
| Q3 25 | 5.2% | 17.9% | ||
| Q2 25 | 3.6% | 16.8% | ||
| Q1 25 | 0.7% | 21.6% | ||
| Q4 24 | 3.8% | 16.9% | ||
| Q3 24 | 12.7% | 15.0% | ||
| Q2 24 | 4.5% | 11.8% |
| Q1 26 | -0.1% | 7.3% | ||
| Q4 25 | -0.8% | 13.2% | ||
| Q3 25 | 3.7% | 11.8% | ||
| Q2 25 | 2.5% | 10.6% | ||
| Q1 25 | 0.3% | 17.5% | ||
| Q4 24 | 2.9% | 10.8% | ||
| Q3 24 | 9.4% | 9.8% | ||
| Q2 24 | 4.4% | 11.4% |
| Q1 26 | $-0.05 | — | ||
| Q4 25 | $-0.35 | $0.95 | ||
| Q3 25 | $1.72 | $0.81 | ||
| Q2 25 | $1.12 | $0.70 | ||
| Q1 25 | $0.13 | $1.17 | ||
| Q4 24 | $1.21 | $0.74 | ||
| Q3 24 | $4.23 | $0.66 | ||
| Q2 24 | $1.96 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.4M | $245.4M |
| Total DebtLower is stronger | $223.7M | $1.2B |
| Stockholders' EquityBook value | $1.3B | $796.3M |
| Total Assets | $2.5B | $2.4B |
| Debt / EquityLower = less leverage | 0.17× | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $86.4M | $245.4M | ||
| Q4 25 | $124.2M | $363.4M | ||
| Q3 25 | $132.6M | $296.4M | ||
| Q2 25 | $139.7M | $292.9M | ||
| Q1 25 | $98.7M | $306.8M | ||
| Q4 24 | $157.2M | $320.8M | ||
| Q3 24 | $191.1M | $299.3M | ||
| Q2 24 | $260.5M | $344.4M |
| Q1 26 | $223.7M | $1.2B | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | $214.1M | $1.2B | ||
| Q2 25 | $241.4M | $1.2B | ||
| Q1 25 | $214.2M | $1.2B | ||
| Q4 24 | $189.1M | — | ||
| Q3 24 | $180.5M | — | ||
| Q2 24 | $203.6M | — |
| Q1 26 | $1.3B | $796.3M | ||
| Q4 25 | $1.3B | $911.5M | ||
| Q3 25 | $1.3B | $849.2M | ||
| Q2 25 | $1.3B | $882.3M | ||
| Q1 25 | $1.3B | $820.8M | ||
| Q4 24 | $1.3B | $906.9M | ||
| Q3 24 | $1.3B | $878.9M | ||
| Q2 24 | $1.2B | $905.4M |
| Q1 26 | $2.5B | $2.4B | ||
| Q4 25 | $2.5B | $2.5B | ||
| Q3 25 | $2.5B | $2.4B | ||
| Q2 25 | $2.5B | $2.5B | ||
| Q1 25 | $2.4B | $2.5B | ||
| Q4 24 | $2.4B | $2.5B | ||
| Q3 24 | $2.4B | $2.5B | ||
| Q2 24 | $2.4B | $2.5B |
| Q1 26 | 0.17× | 1.53× | ||
| Q4 25 | — | 1.34× | ||
| Q3 25 | 0.16× | 1.44× | ||
| Q2 25 | 0.19× | 1.39× | ||
| Q1 25 | 0.17× | 1.49× | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.14× | — | ||
| Q2 24 | 0.17× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $293.2M |
| Free Cash FlowOCF − Capex | — | $209.9M |
| FCF MarginFCF / Revenue | — | 15.7% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | — | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $44.7M | $93.6M | ||
| Q3 25 | $98.2M | $111.3M | ||
| Q2 25 | $108.4M | $17.4M | ||
| Q1 25 | $-22.3M | $116.6M | ||
| Q4 24 | $56.8M | $43.8M | ||
| Q3 24 | $88.8M | $48.8M | ||
| Q2 24 | $133.7M | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $36.9M | $87.2M | ||
| Q3 25 | $33.2M | $106.3M | ||
| Q2 25 | $80.9M | $13.6M | ||
| Q1 25 | $-36.8M | $100.9M | ||
| Q4 24 | $3.5M | $35.2M | ||
| Q3 24 | $23.9M | $39.4M | ||
| Q2 24 | $83.9M | $-33.1M |
| Q1 26 | — | 15.7% | ||
| Q4 25 | 3.8% | 25.7% | ||
| Q3 25 | 3.2% | 32.5% | ||
| Q2 25 | 7.9% | 4.2% | ||
| Q1 25 | -3.8% | 30.5% | ||
| Q4 24 | 0.4% | 10.1% | ||
| Q3 24 | 2.2% | 11.4% | ||
| Q2 24 | 7.8% | -9.8% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 0.8% | 1.9% | ||
| Q3 25 | 6.2% | 1.5% | ||
| Q2 25 | 2.7% | 1.2% | ||
| Q1 25 | 1.5% | 4.7% | ||
| Q4 24 | 5.3% | 2.5% | ||
| Q3 24 | 6.1% | 2.7% | ||
| Q2 24 | 4.6% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | — | 2.09× | ||
| Q3 25 | 2.50× | 2.88× | ||
| Q2 25 | 4.20× | 0.51× | ||
| Q1 25 | -7.13× | 2.01× | ||
| Q4 24 | 1.96× | 1.17× | ||
| Q3 24 | 0.89× | 1.44× | ||
| Q2 24 | 2.85× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
